598 related articles for article (PubMed ID: 27983747)
1. Laboratory and Clinical Monitoring of Direct Acting Oral Anticoagulants: What Clinicians Need to Know.
Conway SE; Hwang AY; Ponte CD; Gums JG
Pharmacotherapy; 2017 Feb; 37(2):236-248. PubMed ID: 27983747
[TBL] [Abstract][Full Text] [Related]
2. Measurement and reversal of the direct oral anticoagulants.
Samuelson BT; Cuker A
Blood Rev; 2017 Jan; 31(1):77-84. PubMed ID: 27625113
[TBL] [Abstract][Full Text] [Related]
3. Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP) - March 2013.
Pernod G; Albaladejo P; Godier A; Samama CM; Susen S; Gruel Y; Blais N; Fontana P; Cohen A; Llau JV; Rosencher N; Schved JF; de Maistre E; Samama MM; Mismetti P; Sié P;
Arch Cardiovasc Dis; 2013; 106(6-7):382-93. PubMed ID: 23810130
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic and Pharmacodynamic Drug Monitoring of Direct-Acting Oral Anticoagulants: Where Do We Stand?
Wieland E; Shipkova M
Ther Drug Monit; 2019 Apr; 41(2):180-191. PubMed ID: 30883512
[TBL] [Abstract][Full Text] [Related]
5. Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians.
Douxfils J; Ageno W; Samama CM; Lessire S; Ten Cate H; Verhamme P; Dogné JM; Mullier F
J Thromb Haemost; 2018 Feb; 16(2):209-219. PubMed ID: 29193737
[TBL] [Abstract][Full Text] [Related]
6. Direct oral anticoagulants: new drugs and new concepts.
Levy JH; Spyropoulos AC; Samama CM; Douketis J
JACC Cardiovasc Interv; 2014 Dec; 7(12):1333-51. PubMed ID: 25523529
[TBL] [Abstract][Full Text] [Related]
7. Reversal agents for direct oral anticoagulants: considerations for hospital physicians and intensivists.
Desai NR; Cornutt D
Hosp Pract (1995); 2019 Aug; 47(3):113-122. PubMed ID: 31317796
[TBL] [Abstract][Full Text] [Related]
8. Laboratory Assessment of the Anticoagulant Activity of Direct Oral Anticoagulants: A Systematic Review.
Samuelson BT; Cuker A; Siegal DM; Crowther M; Garcia DA
Chest; 2017 Jan; 151(1):127-138. PubMed ID: 27637548
[TBL] [Abstract][Full Text] [Related]
9. Volume and Characteristics of Intracerebral Hemorrhage with Direct Oral Anticoagulants in Comparison with Warfarin
.
Adachi T; Hoshino H; Takagi M; Fujioka S;
Cerebrovasc Dis Extra; 2017; 7(1):62-71. PubMed ID: 28376486
[TBL] [Abstract][Full Text] [Related]
10. Limitations of Specific Coagulation Tests for Direct Oral Anticoagulants: A Critical Analysis.
Ebner M; Birschmann I; Peter A; Härtig F; Spencer C; Kuhn J; Rupp A; Blumenstock G; Zuern CS; Ziemann U; Poli S
J Am Heart Assoc; 2018 Oct; 7(19):e009807. PubMed ID: 30371316
[TBL] [Abstract][Full Text] [Related]
11. Direct oral anticoagulants (DOACs).
Vazquez S; Rondina MT
Vasc Med; 2015 Dec; 20(6):575-7. PubMed ID: 26285587
[TBL] [Abstract][Full Text] [Related]
12. Laboratory measurement of the direct oral anticoagulants.
Dale BJ; Chan NC; Eikelboom JW
Br J Haematol; 2016 Feb; 172(3):315-36. PubMed ID: 26492202
[TBL] [Abstract][Full Text] [Related]
13. Reversing the anticoagulation effects of dabigatran.
Dager WE; Banares L
Hosp Pract (1995); 2017 Apr; 45(2):29-38. PubMed ID: 28335637
[TBL] [Abstract][Full Text] [Related]
14. Newer oral anticoagulants: a review of laboratory monitoring options and reversal agents in the hemorrhagic patient.
Miyares MA; Davis K
Am J Health Syst Pharm; 2012 Sep; 69(17):1473-84. PubMed ID: 22899742
[TBL] [Abstract][Full Text] [Related]
15. Direct oral anticoagulants and heparins: laboratory values and pitfalls in 'bridging therapy'.
Eller T; Flieder T; Fox V; Gripp T; Dittrich M; Kuhn J; Alban S; Knabbe C; Birschmann I
Eur J Cardiothorac Surg; 2017 Apr; 51(4):624-632. PubMed ID: 28043992
[TBL] [Abstract][Full Text] [Related]
16. Challenges to Laboratory Monitoring of Direct Oral Anticoagulants.
Qiao J; Tran MH
Clin Appl Thromb Hemost; 2024; 30():10760296241241524. PubMed ID: 38650302
[TBL] [Abstract][Full Text] [Related]
17. Direct Oral Anticoagulants (DOACs) in the Laboratory: 2015 Review.
Adcock DM; Gosselin R
Thromb Res; 2015 Jul; 136(1):7-12. PubMed ID: 25981138
[TBL] [Abstract][Full Text] [Related]
18. Specific antidotes against direct oral anticoagulants: A comprehensive review of clinical trials data.
Tummala R; Kavtaradze A; Gupta A; Ghosh RK
Int J Cardiol; 2016 Jul; 214():292-8. PubMed ID: 27082776
[TBL] [Abstract][Full Text] [Related]
19. An update on laboratory assessment for direct oral anticoagulants (DOACs).
Gosselin RC; Adcock DM; Douxfils J
Int J Lab Hematol; 2019 May; 41 Suppl 1():33-39. PubMed ID: 31069969
[TBL] [Abstract][Full Text] [Related]
20. [Clinical perspectives on the management of bleeding in patients on oral anticoagulants: the DECOVER Study (DElphi Consensus on oral COagulation and therapy action reVERsal)].
Vicente V; Martín A; Lecumberri R; Coll-Vinent B; Suero C; González-Porras JR; Marco P; Mateo J; Roldán V; Soulard S; Crespo C; Camats M;
Emergencias; 2017 Feb; 29(1):18-26. PubMed ID: 28825264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
